Search results
...Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal...
FOX 59 Indianapolis· 4 days agoUnder the terms of the agreement, Nona Biosciences shall receive US$19 million upon completion...
AstraZeneca to build $1.5 bln cancer drug facility in Singapore
Medical Xpress· 6 days agoBritish pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 6 days agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
BioPharma Dive via Yahoo Finance· 4 days agoA new obesity drug developer from investment firm Versant Ventures is starting up with a deal to...
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 5 days agoThe biggest company on London’s stock market, AstraZeneca, set out bold plans today for what it’s...
AstraZeneca to establish $1.5bn ADC production site in Singapore
Pharmaceutical Technology via Yahoo Finance· 5 days agoAstraZeneca is set to invest $1.5bn in a new manufacturing facility in Singapore dedicated to...
AstraZeneca aims to deliver $80 billion in total revenue by 2030
KFGO· 5 days ago(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030,...
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
Investopedia· 5 days agoAstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after...